Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans.
Cryptococcus neoformans is a human opportunistic fungal pathogen responsible for approximately 1/3 of HIV/AIDS deaths worldwide. This budding yeast expresses a polysaccharide capsule necessary for virulence. Capsule production inhibits phagocytosis by macrophages. Here we describe results that link copper homeostasis to capsule production and the inhibition of phagocytosis. Specifically, using Agrobacterium-mediated insertional mutagenesis, we identified an insertion in the promoter region of the putative copper transporter-encoding gene CTR2 that results in reduced expression of CTR2 and increased phagocytosis by murine RAW264.7 macrophages. The mutant also displayed sensitivity to copper starvation and defects in polysaccharide capsule production and melanization. These defects were all reversed by genetic correction of the promoter insertion by homologous targeting. Several melanization-defective mutants identified previously, those in the RIM20, RIM101, and VPS25 genes, also display sensitivity to copper starvation, reduced capsule production and increased phagocytosis. Together these results indicate a previously undescribed link between copper homeostasis to polysaccharide capsule production and phagocytosis inhibition in Cryptococcus neoformans.
Chun
Cheryl D
CD
Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, United States of America.
Madhani
Hiten D
HD
D000595:Amino Acid Sequence; D000818:Animals; D027682:Cation Transport Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D003300:Copper / Q000378:metabolism*; D003453:Cryptococcosis / Q000276:immunology* / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D015536:Down-Regulation; D005656:Fungal Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D008264:Macrophages / Q000276:immunology / Q000382:microbiology; D051379:Mice; D008969:Molecular Sequence Data; D010587:Phagocytosis; D011134:Polysaccharides / Q000378:metabolism*; D016415:Sequence Alignment
D027682:Cation Transport Proteins; D005656:Fungal Proteins; D011134:Polysaccharides; D003300:Copper
PLoS Pathog. 2008 Feb 8;4(2):e45
18282105
J Immunol. 1989 Jan 15;142(2):659-65
2521352
Mol Microbiol. 1989 Jul;3(7):969-77
2796734
Biosci Rep. 2002 Oct-Dec;22(5-6):529-40
12635850
Infect Immun. 1981 Jun;32(3):975-8
6265377
Eukaryot Cell. 2006 Jun;5(6):935-44
16757741
PLoS One. 2008 Jan 23;3(1):e1473
18213381
J Bacteriol. 1982 Jun;150(3):1414-21
6804444
Mol Biol Cell. 2006 Mar;17(3):1344-53
16407402
Mol Genet Genomics. 2005 Nov;274(4):402-9
16133162
Yeast. 1997 Dec;13(15):1423-35
9434348
Cell Microbiol. 2008 Feb;10(2):277-84
18042257
J Biol Chem. 1995 Nov 24;270(47):28479-86
7499355
J Biol Chem. 2002 Nov 29;277(48):46676-86
12244050
Infect Immun. 2009 Sep;77(9):3749-58
19564388
PLoS Genet. 2006 Nov 17;2(11):e187
17112316
Eur J Immunol. 2003 Jul;33(7):1957-67
12884862
Mol Biol Cell. 2006 Dec;17(12):5131-40
17021252
Mol Genet Genomics. 2001 Jul;265(5):873-82
11523804
PCR Methods Appl. 1991 Aug;1(1):39-42
1842919
Infect Immun. 1986 Jan;51(1):218-23
3079732
J Bacteriol. 1968 Jan;95(1):5-8
4866104
Biol Proced Online. 2004;6:10-15
15103395
Methods Enzymol. 2010;470:797-831
20946836
Infect Immun. 1997 Feb;65(2):718-28
9009335
J Biol Chem. 2002 Jul 19;277(29):26021-30
11983704
J Clin Invest. 2007 Mar;117(3):794-802
17290306
Infect Immun. 1999 May;67(5):2357-65
10225895
Fungal Genet Biol. 2005 Nov;42(11):904-13
16260158
Annu Rev Microbiol. 2009;63:223-47
19575556
Cell. 2008 Oct 3;135(1):174-88
18854164
Am J Physiol. 1983 Sep;245(3):C220-6
6614156
PLoS Pathog. 2010 Feb 19;6(2):e1000776
20174553
Infect Immun. 2004 Mar;72(3):1693-9
14977977
Toxicol Sci. 2008 Jan;101(1):140-51
17785683
AIDS. 2009 Feb 20;23(4):525-30
19182676